Methadone maintenance treatment modalities in relation to incidence of HIV: Results of the Amsterdam cohort study

AIDS

Volumn 13, Issue 13, 1999, Pages 1711-1716

  Langendam, Miranda W ^a,b   Van Brussel, Giel H A ^a   Coutinho, Roel A ^a   Van Ameijden, Erik J C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MUNICIPAL HEALTH SERVICE   (Netherlands)

Author keywords

Evaluation; HIV infection; Methadone treatment programmes; Substance abuse

Indexed keywords

METHADONE;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; HOMELESSNESS; HOSPITAL CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MULTIVARIATE ANALYSIS; NETHERLANDS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK FACTOR; SEROCONVERSION;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; MALE; METHADONE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NARCOTICS; NETHERLANDS; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS;

EID: 0033371829     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199909100-00015     Document Type: Article

References (22)

1. Drucker E, Lurie P, Wodak A, Alcabes, P. Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS 1998, 12 (suppl A):S217-S230.
2. Yancovitz SR, Des Jarlais DC, Peskoe N, et al. A randomized trial of an interim methadone maintenance clinic. Am J Public Health 1991, 81:1185-1191.
3. Stark K, Müller R, Bienzle U, Guggenmoos-Holzmann I. Methadone maintenance treatment and HIV risk-taking behavior among injecting drug users in Berlin. J Epidemiol Comm Health 1996, 50:534-537.
4. Ball JC, Lange WR, Myers CP, Friedman SR. Reducing the risk of AIDS through methadone maintenance treatment. J Health Social Behav 1988, 29:214-226.
5. Baker A, Kochan N, Dixon J, Wodak A, Heather N. HIV risk-taking behavior among injecting drug users currently, previously and never enrolled in methadone treatment. Addiction 1995, 90:545-554.
6. Serpelloni G, Carrieri MP, Rezza G, et al. Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study. AIDS Care 1994, 6:215-220.
7. Williams AB, McNelly EA, Williams AE, et al. Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users. AIDS Care 1992, 4:35-41.
8. Novick DM, Joseph H, Croxson TS, et al. Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients. Arch Intern Med 1990, 150:97-99.
9. Metzger DS, Woody GE, McLellan AT, et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr 1993, 6:1049-1056.
10. Buning EC, Coutinho RA, van Brussel GHA, et al. Preventing AIDS in drug addicts in Amsterdam [letter]. Lancet 1986, 1:1435.
11. Plomp HN, van der Hek H, Adèr HJ. The Amsterdam Methadone Dispensing Circuit: genesis and effectiveness of a public health model for local drug policy. Addiction 1996, 91:711-721.
12. Langendam MW, van Haastrecht HJA, van Brussel GHA, et al. Differentiation in the Amsterdam methadone dispensing circuit: determinants of methadone dosage and site of methadone prescription. Addiction 1998, 93:61-72.
13. van den Hoek JAR, Coutinho RA, van Haastrecht HJA, et al. Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS 1988, 2:55-60.
14. van den Hoek JAR, van Haastrecht HJA, Coutinho RA. Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. Am J Public Health 1989, 79:1355-1357.
15. van Haastrecht HJA, van den Hoek JAR, Bardoux C, Leentvaar-Kuijpers A, Coutinho RA. The course of the HIV epidemic among intravenous drug users in Amsterdam, The Netherlands. Am J Public Health 1991, 81:59-62.
16. Horsburgh CR, Yih OU C, Jason J, et al. Duration of human immunodeficiency virus infection before detection of antibody. Lancet 1989, 8664:637-639.
17. Bruisten SM, Mientjes GHC, van Delft P, et al. HIV-1 infection detected by polymerase chain reaction frequently precedes antibody seroconversion in drug users [letter]. AIDS 1994, 8:1736-1737.
18. Hartel DM, Schoenbaum EE, Selwyn PA, et al. Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am J Public Health 1995, 85:83-88.
19. Caplehorn JRM, Bell J, Kleinbaum DG, Gebski VJ. Methadone dose and heroin during maintenance treatment. Addiction 1993, 88:119-124.
20. Bell J, Chan J, Kuk A. Investigation the influence of treatment philosophy on outcome of methadone maintenance. Addiction 1995, 90:823-830.
21. van Haastrecht HJA, Bax J, van den Hoek JAR. High rates of drug use, but low rates of HIV risk behaviours among injecting drug users during incarceration in Dutch prisons. Addiction 1998, 93:1417-1425.
22. Cooper JR. Methadone treatment and acquired immunodeficiency syndrome. JAMA 1989, 262:22-29.